olivLaw · US equity research
Ascent Industries Co. ACNT
Chemicals & Allied Products · SIC 2800 · Vertical: Chemicals & Allied Products (SIC 2800)
Ascent Industries Co. is a specialty chemicals platform that supplies tailored formulations and intermediates to energy, household, personal care and coatings customers. The company returned to growth in the second quarter of 2026, with net sales of $25.7 million, helped by the Midwest Graphic Sales acquisition and higher average selling prices.
The AI analysis may be outdated: new filings came after its sources (see the «AI analysis» section).
At the close of 04 Nov 2026, Ascent Industries Co. (ACNT) stock was 13.74 USD (−0.29% on the day), with market capitalisation 124.0 m USD, dividend yield 0.00%, beta 0.20, 52-week range 12.12–17.78 USD. Latest reported quarter (Q3 2026): revenue of 27.1 m USD (+37.8% YoY), net income of 1.4 m USD, diluted EPS 0.15 USD.
Data as of · AI analysis dated · Source: SEC filings and closing prices, computed by olivLaw.
Price history
Loading chart…
Technical reading
- RSI (14)
- 45.1
- neutral
- Bollinger (20, 2)
- 13.42 – 13.93
- in the upper half of the band · %B 0.63 · band width 3.7%
- SMA 50 / 200
- 14.32 / 14.63
- downtrend (price < SMA50 < SMA200)
- MACD (12, 26, 9)
- -0.13 / -0.19
- MACD above signal
Indicators describe past prices; on their own they do not predict direction. On our history the RSI ≤ 40 filter added no return (see the signals methodology).
Performance
| Company | S&P 500 | vs S&P 500 | Vertical median | |
|---|---|---|---|---|
| 1 month | +0.4% | −1.1% | +1.5 pp | — |
| 3 months | −11.8% | −0.5% | −11.4 pp | — |
| 6 months | −5.8% | +4.4% | −10.2 pp | — |
| Year to date | −15.1% | +12.3% | −27.4 pp | — |
| 1 year | +14.8% | +13.5% | +1.2 pp | +3.3% |
| 3 years | +61.6% | +76.4% | −14.8 pp | −49.7% |
| 5 years | +15.2% | +63.7% | −48.5 pp | — |
Price returns, dividends excluded.
Quarterly results
Latest quarter: Q3 2026 · 30 Sept 2026
Quarterly margins
Quarterly statements · USD
| Fiscal year | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18.1 m | 17.8 m | 18.7 m | 19.7 m | 18.8 m | 19.4 m | 25.7 m | 27.1 m |
| Cost of revenue | 14.6 m | 14.8 m | 13.8 m | 13.9 m | 15.3 m | 16.6 m | 20.1 m | 20.0 m |
| Gross profit | 3.5 m | 3.1 m | 4.9 m | 5.8 m | 3.4 m | 2.8 m | 5.5 m | 7.1 m |
| Research & development | — | 0 | 0 | 0 | 71.0 k | 63.0 k | 107.0 k | 92.0 k |
| SG&A | 4.3 m | 4.6 m | 6.1 m | 6.0 m | 6.7 m | 4.9 m | 5.0 m | 4.6 m |
| Operating income | -2.5 m | -2.0 m | -2.7 m | -810.0 k | -1.5 m | -2.4 m | -262.0 k | 1.6 m |
| Depreciation & amortisation | — | 236.0 k | 359.0 k | 282.0 k | -127.0 k | 250.0 k | 506.0 k | 718.0 k |
| Interest expense | 95.0 k | 115.0 k | -15.0 k | -447.0 k | — | — | 104.0 k | 93.0 k |
| Pre-tax income | -2.5 m | -2.0 m | -2.5 m | -67.0 k | -953.0 k | -1.9 m | 69.0 k | 1.9 m |
| Income tax | -2.6 m | 169.0 k | -89.0 k | 58.0 k | 54.0 k | 114.0 k | -601.0 k | 495.0 k |
| Net income | -1.0 m | -2.3 m | 6.3 m | -2.1 m | -1.0 m | -2.0 m | 670.0 k | 1.4 m |
| Diluted EPS | -0.10 ≈ | -0.23 | 0.65 | -0.22 | -0.11 ≈ | -0.21 | 0.07 | 0.15 |
| Operating cash flow | 8.8 m | -700.0 k | -1.4 m ≈ | 1.3 m ≈ | 266.0 k | -5.4 m | -2.3 m ≈ | 2.3 m ≈ |
| Capex | 383.0 k | 318.0 k | 148.0 k ≈ | 616.0 k ≈ | 462.0 k | 422.0 k | 754.0 k ≈ | 1.1 m ≈ |
| Share repurchases | 299.0 k | 215.0 k | 7.8 m ≈ | 831.0 k ≈ | 262.0 k | 3.9 m | 2.9 m ≈ | 0 ≈ |
≈ derived quarter (cumulative difference / share-days average)
E/P over time
E/P = trailing-12-month diluted EPS / price at quarter end. E/P is the inverse of P/E and stays defined when earnings are negative.
Fiscal years
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | ⚠ 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 280.8 m | 305.2 m | 256.0 m | 334.7 m | 262.0 m | 193.2 m | 80.8 m | 74.9 m |
| Revenue YoY | +39.6% | +8.7% | −16.1% | +30.7% | −21.7% | −26.3% | — | −7.2% |
| Net income | 13.1 m | -3.0 m | -27.3 m | 20.2 m | 22.1 m | -26.6 m | -13.6 m | 867.0 k |
| Net income YoY | +876.7% | −123.2% | unavailable | unavailable | +9.0% | −220.7% | — | unavailable |
| Diluted EPS | unavailable | -0.34 | -2.98 | 2.14 | 2.12 | -2.63 | -1.35 | 0.09 |
| Diluted EPS YoY | unavailable | unavailable | unavailable | unavailable | −0.9% | −224.1% | — | unavailable |
| net % | 4.7% | -1.0% | -10.7% | 6.0% | 8.4% | -13.8% | -16.8% | 1.2% |
| Free cash flow | -28.6 m | 24.1 m | 14.2 m | 17.6 m | 2.2 m | 20.2 m | 13.6 m | -2.1 m |
The series breaks before 2024: earlier years come from the original reports of the issuer of that time, later years from a subsequent filing that restated the perimeter (a separation, discontinued operations). The year-on-year change across the break is not shown.
Reported results vs expectations
Loading…
Balance sheet & financial health
Fiscal year 2025 · 31 Dec 2025
- Cash
- 57.6 m USD
- Financial debt
- unavailable USD
- Net debt
- unavailable USD
- Equity
- 87.0 m USD
- Total assets
- 111.9 m USD
- Debt / equity
- unavailable
- Current ratio
- 6.72x
- ROE
- 1.0%
- ROA
- 0.7%
- FCF margin
- -2.8%
Financial statements (source on every figure)
Revenue and net income (USD)
Margins
Income statement · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Revenue | 256.0 m | 334.7 m | 262.0 m | 193.2 m | 80.8 m | 74.9 m | SEC (XBRL)· 03 Mar 2026verified |
| Cost of revenue | 233.3 m | 273.9 m | 218.7 m | 191.7 m | 70.1 m | 57.7 m | SEC (XBRL)· 03 Mar 2026verified |
| Gross profit | 22.7 m | 60.8 m | 43.3 m | 1.5 m | 10.7 m | 17.2 m | SEC (XBRL)· 03 Mar 2026verified |
| Research & development | 500.0 k | — | — | — | 0 | 71.0 k | SEC (XBRL)· 03 Mar 2026verified |
| SG&A | 28.7 m | 30.1 m | 27.6 m | 26.7 m | 19.9 m | 23.0 m | SEC (XBRL)· 03 Mar 2026verified |
| Operating income | -31.1 m | 27.3 m | 14.5 m | -37.4 m | -10.8 m | -7.0 m | SEC (XBRL)· 03 Mar 2026verified |
| Depreciation & amortisation | 10.6 m | 10.3 m | 12.7 m | — | 1.0 m | 1.1 m | SEC (XBRL)· 03 Mar 2026verified |
| EBITDA | -20.5 m ≈ | 37.7 m ≈ | 27.3 m ≈ | — | -9.8 m ≈ | -5.9 m ≈ | SEC (XBRL)· 03 Mar 2026derived |
| Interest expense | 2.1 m | 1.5 m | 2.7 m | 4.2 m | 418.0 k | — | SEC (XBRL)· 04 Mar 2025verified |
| Pre-tax income | -32.0 m | 25.5 m | 12.0 m | -41.1 m | -10.8 m | -5.6 m | SEC (XBRL)· 03 Mar 2026verified |
| Income tax | -4.7 m | 5.3 m | -5.6 m | -6.9 m | 1.8 m | 22.0 k | SEC (XBRL)· 03 Mar 2026verified |
| Net income | -27.3 m | 20.2 m | 22.1 m | -26.6 m | -13.6 m | 867.0 k | SEC (XBRL)· 03 Mar 2026verified |
| Diluted EPS | -2.98 | 2.14 | 2.12 | -2.63 | -1.35 | 0.09 | SEC (XBRL)· 03 Mar 2026verified |
| Weighted average diluted shares | 9.1 m | 9.5 m | 10.4 m | 10.1 m | 10.1 m | 9.6 m | SEC (XBRL)· 03 Mar 2026verified |
| Dividend per share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | SEC (XBRL)· 03 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating income + Depreciation & amortisation.
Balance sheet · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Cash | 236.0 k | 2.0 m | 1.4 m | 1.9 m | 16.1 m | 57.6 m | SEC (XBRL)· 03 Mar 2026verified |
| Receivables | 28.2 m | 33.4 m | 33.2 m | 15.1 m | 12.2 m | 10.0 m | SEC (XBRL)· 03 Mar 2026verified |
| Inventories | 85.1 m | 103.2 m | 67.7 m | 52.3 m | 5.7 m | 8.7 m | SEC (XBRL)· 03 Mar 2026verified |
| Current assets | 126.9 m | 160.0 m | 170.4 m | 89.4 m | 83.1 m | 83.0 m | SEC (XBRL)· 03 Mar 2026verified |
| Goodwill | 1.4 m | 12.6 m | 11.4 m | 0 | 0 | 0 | SEC (XBRL)· 04 Aug 2026verified |
| Intangibles (excl. goodwill) | 11.4 m | 14.4 m | 10.0 m | 8.5 m | 3.4 m | 2.8 m | SEC (XBRL)· 03 Mar 2026verified |
| Total assets | 207.0 m | 266.0 m | 269.0 m | 163.3 m | 147.3 m | 111.9 m | SEC (XBRL)· 03 Mar 2026verified |
| Accounts payable | 19.7 m | 32.3 m | 14.1 m | 16.4 m | 6.8 m | 5.5 m | SEC (XBRL)· 03 Mar 2026verified |
| Short-term debt | 875.0 k | 2.5 m | 2.5 m | 0 | — | — | SEC (XBRL)· 01 Apr 2024verified |
| Long-term debt | 60.5 m | 67.9 m | 69.1 m | 0 | 0 | — | SEC (XBRL)· 04 Mar 2025verified |
| Current liabilities | 31.1 m | 50.5 m | 33.5 m | 24.8 m | 22.3 m | 12.4 m | SEC (XBRL)· 03 Mar 2026verified |
| Total liabilities | 126.7 m | 154.4 m | 134.8 m | 55.9 m | 53.7 m | 24.9 m | SEC (XBRL)· 03 Mar 2026verified |
| Equity | 80.3 m † | 111.6 m † | 134.3 m † | 107.4 m † | 93.5 m † | 87.0 m † | SEC (XBRL)· 03 Mar 2026verified |
† equity attributable to the parent's shareholders: in these years the issuer no longer reports the total including non-controlling interests.
Cash flow · USD
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Source (latest year) |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.0 m | 19.1 m | 5.6 m | 23.1 m | 14.7 m | -519.0 k | SEC (XBRL)· 03 Mar 2026verified |
| Capex | 3.7 m | 1.5 m | 3.4 m | 2.9 m | 1.1 m | 1.5 m | SEC (XBRL)· 03 Mar 2026verified |
| Free cash flow | 14.2 m ≈ | 17.6 m ≈ | 2.2 m ≈ | 20.2 m ≈ | 13.6 m ≈ | -2.1 m ≈ | SEC (XBRL)· 03 Mar 2026derived |
| Investing cash flow | 994.0 k | -32.7 m | -5.0 m | 50.5 m | 905.0 k | 51.0 m | SEC (XBRL)· 03 Mar 2026verified |
| Financing cash flow | -19.4 m | 15.4 m | -1.2 m | -73.2 m | -1.3 m | -9.0 m | SEC (XBRL)· 03 Mar 2026verified |
| Share repurchases | 635.0 k | 0 | 1.3 m | 1.3 m | 1.0 m | 9.1 m | SEC (XBRL)· 03 Mar 2026verified |
≈ computed by olivLaw from the reported lines of the same year: Operating cash flow − Capex.
Computed indicators
Growth
Profitability
Returns
Balance sheet
Liquidity
Cash
Efficiency
Market and valuation
Risk
Valuation
olivLaw classification
- score weight coverage: 47.9% of at least 60%
- valuation methods computed: 0 of at least 1
A scoring methodology on indicators and valuation, not investment advice.
Closing price
04 Nov 2026Source: olivLaw, closing series
Market cap: 124.0 m USD
Key indicators
Coverage and freshness
Score by group
48% · Insufficient data
Estimated value range
unavailable — no valuation method could be computed
Valuation assumptions are editorial choices, not measured; beta is not measured.
Valuation methods
- DCF (discounted cash flow)unavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: EV/EBITDAunavailable · net debt missing: EV cannot be bridged to equity (missing debt is not zero)
- Peers: P/Eunavailable · the base of the ratio is not positive
- Dividend discount (DDM)unavailable · the base of the ratio is not positive
no valuation method could be computed
Classification (SIC) comparables group by industry code, not by economic activity; the direct group is an editorial selection by activity. Members' multiples are on their own trailing twelve months, at their own latest close.
Assumptions (illustrative, editorial)
- Risk-free rate
- 4.3%
- Equity risk premium
- 5.0%
- Beta (default)
- 1.00
- Cost of equity
- 9.3%
- Terminal growth
- 2.5%
Factor scorecard
Insufficient data
Minimum-evidence gate: score weight coverage: 47.9% of at least 60%; valuation methods computed: 0 of at least 1
| Factor | Value | Score | Weight used |
|---|---|---|---|
| ROIC · Quality | unavailable | unavailable | — |
| Net margin · Quality | -1.0% | 71 (vs peers) | 13% |
| FCF conversion · Quality | unavailable | unavailable | — |
| Revenue CAGR 3Y · Growth | -34.1% | 0 (on a fixed band) | 17% |
| EPS CAGR 3Y · Growth | -65.1% | 0 (on a fixed band) | 17% |
| Net debt / EBITDA · Balance sheet | unavailable | unavailable | — |
| Interest coverage · Balance sheet | -9.9x | 0 (on a fixed band) | 13% |
| Current ratio · Balance sheet | 4.5x | 100 (on a fixed band) | 9% |
| P/E (TTM) · Valuation | unavailable | unavailable | — |
| EV/EBITDA · Valuation | unavailable | unavailable | — |
| FCF yield · Valuation | -6.4% | 0 (on a fixed band) | 17% |
| Shareholder yield (distributions) · Returns | 5.7% | 82 (on a fixed band) | 13% |
| Payout ratio (FCF) · Returns | unavailable | unavailable | — |
Factors without a value were dropped; the remaining weights were renormalised.
Score groups
- Balance sheet40/100 · 2/3 factors with a value
- Growth0/100 · 2/2 factors with a value
- Quality· partial71/100 · 1/3 factors with a value
- Returns· partial82/100 · 1/2 factors with a value
- Valuation· partial0/100 · 1/3 factors with a value
A «partial» group is computed from under half of its weight or from one factor: it is not a full assessment of the group.
Memo
Ascent Industries Co. (ACNT). Latest full fiscal year: 2025; data up to 2026-09-30.
Figures computed from the financial statements: revenue 74.9 m USD in 2025; YoY growth -7.2%; net margin -1.0%; ROE -1.1%.
Valuation cannot be computed from the available data.
Insufficient data for a verdict (score weight coverage: 47.9% of at least 60%; valuation methods computed: 0 of at least 1).
Text generated deterministically from the figures shown; no language model. Not investment advice.
What supports the thesis
- Net margin: -1.0%
- Current ratio: 4.5x
- Shareholder yield (distributions): 5.7%
What contradicts it
- Revenue CAGR 3Y: -34.1%
- EPS CAGR 3Y: -65.1%
- Interest coverage: -9.9x
- FCF yield: -6.4%
Not assessed (insufficient data or a ratio without meaning): ROIC, FCF conversion, Net debt / EBITDA, P/E (TTM), EV/EBITDA, Payout ratio (FCF).
Versus the vertical median
Chemicals & Allied Products (SIC 2800) · same industry (4-digit SIC) · compared with 14 companies
Multiples and returns vs the median
Price rebased to 100 (monthly, 5 years)
Companies in the vertical
| Market cap | P/E | ROE | Net margin | Revenue YoY | 1A / 3A | |
|---|---|---|---|---|---|---|
| SOLSSolstice Advanced Materials Inc. | 9.1 bn | 28.3 | 13.6% | 7.8% | +3.1% | +21% / unavailable |
| BCPCBalchem Corporation | 5.8 bn | 34.4 | 13.0% | 15.4% | +8.8% | +17% / +46% |
| PRMPerimeter Solutions, Inc. | 4.6 bn | — | -30.9% | -44.9% | +16.4% | +1% / +575% |
| NGVTIngevity Corporation | 2.5 bn | 50.1 | 64.4% | 4.7% | −2.7% | +41% / +90% |
| CCThe Chemours Company | 2.1 bn | — | -339.7% | -5.2% | +0.4% | +8% / −50% |
| OLNOlin Corporation | 2.1 bn | — | -12.2% | -3.3% | +3.7% | −14% / −62% |
| IOSPInnospec Inc. | 2.0 bn | 14.2 | 10.5% | 7.5% | −3.7% | +8% / −23% |
| HUNHuntsman Corporation | 1.7 bn | — | -11.8% | -5.8% | −5.8% | −5% / −60% |
| ECVTEcovyst Inc. | 1.1 bn | — | -9.6% | -7.1% | +20.9% | +8% / +5% |
| FMCFmc Corporation | 998.7 m | — | -226.7% | -151.2% | −18.3% | −55% / −88% |
| ACNTAscent Industries Co. | 124.0 m | — | -1.1% | -1.0% | −7.2% | +15% / +62% |
| CITRCitroTech Inc. | 54.8 m | — | -431.0% | -1,788.4% | +194.6% | unavailable / unavailable |
| LOOPLoop Industries, Inc. | 13.0 m | — | — | -2,154.3% | −95.3% | −77% / −92% |
| GUREGulf Resources, Inc. | 5.6 m | — | -32.4% | -134.4% | +231.8% | +3% / −80% |
| ADURAduro Clean Technologies Inc. | — | — | -133.8% | -5,253.1% | −31.5% | −26% / unavailable |
1- and 3-year price returns: for ACNT from daily closes (the same as the performance table), for the other companies from month-end closes.
olivLaw engine forecast
The world engine ran after the company's latest material disclosure. Probabilities are of TOUCHING a level within the horizon (not closing there) and sit next to the random walk (p_rw), the no-information benchmark.
The engine has no published run for this company yet.
Valuation scenarios (editable assumptions)
Illustrative scenarios
Illustrative: not forecasts and without probabilities. Each case is one coherent set of assumptions, computed on today's figures.
Estimated price (USD)
| Estimated price | Bear | Base | Bull |
|---|---|---|---|
| 1 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 3 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
| 5 years | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable | insufficient data Total return unavailable · Per year unavailable |
AI analysis
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 04 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).
In brief
Ascent Industries Co. is a specialty chemicals platform that supplies tailored formulations and intermediates to energy, household, personal care and coatings customers. The company returned to growth in the second quarter of 2026, with net sales of $25.7 million, helped by the Midwest Graphic Sales acquisition and higher average selling prices.
SWOT
Strengths
- A diversified portfolio of formulations and custom manufacturing services supports close technical relationships with customers 1.
- The balance sheet showed no debt at June 30, 2026, giving the company financial flexibility 2.
- Management integrated a recent acquisition quickly and reported profit contribution from its first months 3.
Weaknesses
Opportunities
Risks
- Customer concentrationhigh
A small number of large customers account for a significant share of revenues, and losing one could hurt results 1.
- Raw material volatilityhigh
Sharp increases in raw material prices or supply interruptions could compress margins 1.
- Trade and tariff riskmedium
New tariffs or export controls could raise costs and affect customer demand 2.
- Production interruptionsmedium
Equipment failures or facility incidents could halt output, given the specialized nature of some capacity 1.
- Environmental and regulatory riskmedium
Environmental and safety requirements could add compliance costs and capital spending 1.
Investment thesis
What would need to be true (bull case)
- If second-quarter sales growth holds and optimization lifts gross profit, margins could return toward management's targets 3.
- The Midwest Graphic Sales acquisition could add volume and profit if integration continues as planned 3.
- A debt-free balance sheet could provide room for investment and share repurchases 2.
What would break the thesis
- Gross margin remains below the prior-year level, and an incomplete recovery could limit profitability 3.
- If the market stays soft and overcapacity drives prices lower, sales growth may not cover higher costs 1.
- Customer concentration and tariffs could weigh on revenues during a period of uncertainty 1.
What to watch
- Gross margin trend and delivery of the optimization targetQ4 2026
- Contribution of Midwest Graphic Sales to adjusted EBITDAQ3 2026
- Impact of tariffs and IEEPA refunds on input costs2026
- Share of revenues from the top five customersnext 10-K
Products, market & competition
AI-generatedAI-generated analysis (Claude) from cited public sources; it may contain errors. Not investment advice. As of 27 Oct 2026 · Model: claude-haiku-5-5.
Possibly outdated: the newest document it read is from 04 Aug 2026; since then the company filed 8-K (04 Nov 2026 · results), 10-Q (04 Nov 2026).
The business
Ascent Industries Co. develops, manufactures and supplies specialty formulations and intermediates designed to improve product performance and industrial processes 1. The company operates three production facilities in Cleveland (Tennessee), Fountain Inn (South Carolina) and Danville (Virginia) 1. Its portfolio includes surfactants, defoamers, lubricating agents, flame retardants and intermediates, in both petroleum-based and bio-based forms 1. Ascent also offers custom manufacturing services from product development through commercial production 1.
Segments
Specialty Chemicals
The company has one reportable segment, Specialty Chemicals, which covers surfactants, defoamers, lubricants, flame retardants and intermediates 1. Segment net sales fell to $74.9 million in fiscal 2025, mainly because of lower pounds shipped 1. Segment adjusted EBITDA increased from the prior year 1.
Market context
The specialty chemicals market remains competitive, and prices tend to fall when industry capacity exceeds demand, particularly from overcapacity in Asia 1. Raw material, energy and freight costs affect margins, and tariffs add uncertainty 2. The company described the market as soft while reporting higher volumes in the second quarter of 2026 3.
Trends
- Tariffs and trade policymixed
Tariff changes and export controls could raise input costs and weigh on customer demand, although the company says most of its raw materials are domestically sourced 2.
- Operational optimizationtailwind
The platform-wide optimization program targets a run-rate improvement in annualized gross profit that could lift margins if achieved by the end of 2026 3.
- Overcapacity pricing pressureheadwind
Excess capacity in some regions could keep prices under pressure and compress margins 1.
- Acquisition-led growthtailwind
The Midwest Graphic Sales acquisition was immediately accretive to adjusted EBITDA, and integration finished ahead of the original schedule 3.
Competitive position
The company competes with other specialty chemical providers, and its stated advantage lies in technical capabilities and customer relationships 1. Competition from alternative products with better environmental profiles or lower costs could reduce demand and pricing power 1.
- Specialty chemical providers
The sources do not name specific rivals but cite pressure from other specialty chemical providers 1.
- Makers of alternative products with better environmental profiles
Substitutes with lower costs or stronger environmental credentials could displace the company's solutions 1.
- Asian producers with excess capacity
Surplus production in parts of Asia can exert downward pressure on global prices 1.
- Energy-sector chemical suppliers
The company also serves oilfield and energy customers, where competition can be intense 1.
Links, dependencies and risks
Who the company is tied to, from its own SEC filings (customers, suppliers, production, partners, competitors, countries, regulation), from the 5 %+ holders' statements (13D/13G) and from what other companies say about it. Click a node for its evidence; on a listed company the graph moves to it.
Loading the links…
News & filings
In the press
- Ascent Industries Targets $120M Revenue After Specialty Chemicals TransformationYahoo Finance — News · 30 Aug 2026 · EN
The latest news item in our archive is from 30 Aug 2026; the newest SEC filing is from 04 Nov 2026. The press archive comes from the RSS feeds we follow and does not necessarily cover the latest event — the filings alongside do.
SEC filings
- Quarterly report04 Nov 2026
- Current report04 Nov 2026Results of operations · Financial statements and exhibits
- Current report26 Aug 2026Regulation FD disclosure · Financial statements and exhibits
- Quarterly report04 Aug 2026
- Current report04 Aug 2026Results of operations · Financial statements and exhibits
- Current report21 Jul 2026Material agreement · Financial statements and exhibits
- Current report29 Jun 2026Other events
- Current report10 Jun 2026Shareholder vote
- Current report18 May 2026Regulation FD disclosure · Financial statements and exhibits
- Quarterly report06 May 2026
Sources
- [1] Form 10-K, fiscal year ended 2025-12-31 · SEC / Ascent Industries Co. · 03 Mar 2026
- [2] Form 10-Q, quarter ended 2026-06-30 · SEC / Ascent Industries Co. · 04 Aug 2026
- [3] Form 8-K, results release (exhibit 99.1) · SEC / Ascent Industries Co. · 04 Aug 2026
Figures computed by olivLaw from SEC filings and closing prices; the qualitative analysis is AI-generated from cited sources. Not investment advice.